College of Pharmacy

Xavier University of Louisiana

Yingnan Zhao, Ph.D.
Assistant Professor of Pharmacy Management

Telephone Number: 504-520-5699

COP Room 327

Fax Number:
Email Address:


Yingnan Zhao is an assistant professor of pharmacy administration at Division of Clinical and Administrative Sciences. Dr. Zhao holds a master of sciences degree in Medicinal Administration from University of Macau; and a PhD degree in Health Systems Management from Tulane University. She has participated in a variety of projects in health economic evaluation and outcomes research, with an extensive experience in secondary database analysis. Dr. Zhao's current research interests include establishing the essential need for new medications and evaluating new medications comparatively in real-world applications and health care equity in access, quality, and outcome. She is also interested in pharmacoepidemiology with the focus on safety issues in medication treatment and medical informatics to improve quality of patient care. The majority of her research has been conducted in the area of chronic disease (e.g., diabetes and hypertension) and quality of care for health systems.

Educational Background:

  • PhD in Health Systems Management, Tulane University, New Orleans, Louisiana
  • MS in Medicinal Administration, University of Macau, Macau
  • BS in Biological Sciences, Fudan University, Shanghai, China

Selected Publications

Q Shi, YN Zhao, V Fonseca, M Krousel-Wood, L Shi. Racial Disparity of Eye Examinations Among the U.S. Working-Age Population with Diabetes: 2002-2009. Diabetes Care. 2014 May; 37(5):1321-1328.
L Shi, T Thethi, YN Zhao. Diabetes Risk Assessment Models: We Have the Base, But Not Enough? Journal of Diabetes and Its Complications. 2013 Jul-Aug;27(4):305-6.
YN Zhao, C Campbell, V Fonseca, L Shi. Impact of Hypoglycemia Associated with Anti-hyperglycemic Medications on Vascular Risks in Veterans with Type 2 Diabetes Mellitus. Diabetes Care. 2012 May; 35(5):1126-32.
S Liu, YN Zhao, JM Hempe, V Fonseca, L Shi. Economic burden of hypoglycemia in patients with type 2 diabetes. Expert Review of Pharmacoeconomics & Outcomes Research, 2012 Feb; 12(1):47-51.
YN Zhao, J Liu, Y Zhao, T Thethi, V Fonseca, L Shi. Predictors of Duloxetine versus Other Treatments among Veterans with Diabetic Peripheral Neuropathic Pain (DPNP): A Retrospective Study. Pain Practice. 2011 Sept 27. [Epub ahead of print]
L Shi, YN Zhao, V Fonseca, H Ascher-Svanum, Y Chiang, D Winstead. Healthcare Resource Utilization, Adherence and Persistence with Antipsychotic Therapy among Schizophrenia Patients with vs. without Pre-Existing Metabolic Syndrome. Curr Med Res Opin. 2010 Oct;26(10):2499-506.
L Shi, YN Zhao, C Yau, K Szymanski, V Fonseca. Impact of Thiazolidinedione (TZD) Safety Warnings on Medication Use Patterns and Glycemic Control Among Veterans with Diabetes Mellitus. J Diabetes Complications. 2011; 25:143-150.
L Shi, H Ascher-Svanum, YJ Chiang, YN Zhao, V Fonseca, D Winstead. Predictors of Metabolic Monitoring Among Schizophrenia Patients with A New Episode of Second-Generation Antipsychotic Use in the Veterans Health Administration. BMC Psychiatry. 2009 Dec 18;9:80.
X Liu, YN Zhao, LR Cheng. The Role of Pharmacoeconomic Evaluation in Pricing and Reimbursing Medicines and Its Implication to Pharmaceutical Policy in China. Chinese Hospital Management. 2007; 7(26).
F Zhang, Z Li, B Wen, J Jiang, Y He, H Li, YN Zhao, X Song, J Qian, Da Lu, and L Jin. A frequent partial AZFc deletion does not render an increased risk of spermatogenic impairment in East Asians. Ann Hum Genet. 2006 May; 70(Pt 3):304-13.

College of Pharmacy